1 / 10

Neuroendocrine Tumors Market

Neuroendocrine tumors (NETs) consists of complex group of tumors that arise from cells called neuroendocrine cells.<br>

DelveInsight
Download Presentation

Neuroendocrine Tumors Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Neuroendocrine Tumors (NETs) Market Insights, Epidemiology and Market Forecast - 2028

  2. Neuroendocrine Tumors (NET) 01 Neuroendocrine tumors (NETs) consists of complex group of tumors that arise from cells called neuroendocrine cells. 02 They develop predominantly in the digestive or respiratory tracts, but can occur in many areas of the body. 03 They develop when the specialized cells undergo changes causing them to divide uncontrollably and grow into tumor. 04 Neuroendocrine tumors are classified based on different criteria as an anatomic site of origin; symptoms; malignancy; grade and stage. 05 Neuroendocrine tumors is more predominant in males as compared to females. • DelveInsight © 2019 | All rights reserved

  3. NET Epidemiology • NET total prevalent population was approximately 452,900in 2017 in 7 Major Markets (7MM)*. • In US, NET prevalent cases were 199,000in 2017. • Among the European countries, Germany had the highest with 49,600 cases followed by France, which had a prevalent population of 40,000in 2017. Whereas, Spainhad the lowest prevalent population of 27,000. • In 2017, Japanhad 59,000 NET prevalent cases. * 7MM- USA, EU-5(Germany, Spain, Italy, France and UK), Japan • DelveInsight © 2019 | All rights reserved

  4. Market Outlook Neuroendocrine tumors therapeutic market was USD 3,570.0 million in 2017 in seven major markets (7MM) for the study period (2017-2028). The approved as well as off-label products (chemotherapy and cytotoxic agents) and targeted therapies are being used for the NET treatment. The United States accounts for the largest Neuroendocrine tumors market size in comparison to EU5 (the United Kingdom, Germany, Italy, France, and Spain) and Japan. Systemic therapies are the options for treatment of the distant tumors. Radiolabeled Somatostatin Analog therapies are generally considered as targeted therapies. • DelveInsight © 2019 | All rights reserved

  5. Emerging Therapies 01 Drug- Sulfatinib Company- Hutchison MediPharma 02 Drug- Iobenguane I-131: Company- Progenics Pharmaceuticals 03 Drug- Axitinib Company- Pfizer 04 Drug- Carfilzomib Company- Amgen • DelveInsight © 2019 | All rights reserved

  6. Complete Information For complete information on Neuroendocrine Tumors Market Insights, Epidemiology and Market Forecast - 2028 please click the link below CLICK HERE OR Write Us At  info@delveinsight.com • DelveInsight © 2019 | All rights reserved

  7. About DelveInsight 2 1 3 Mission About To provide “insights across the value chain” and helping the organization to take a prudent business decision through the use and analysis of actionable market intelligence. The mission also is to provide the most effective result and efficient service with utmost client care for maintaining a long-term relationship with them. Vision DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for improving their performances to stay ahead of the competitors. To be the most trusted market research & business consulting firm in the world; and to continue enable the Pharma & Bio-Tech companies to achieve their goals with the best strategic insight and competitive solution. The vision also is inclusive of becoming a one-stop solution provider for the entire gamut of drug development process. • DelveInsight © 2019 | All rights reserved

  8. Service Offerings by DelveInsight 2 8 3 1 6 4 5 7 Market Intelligence Opportunity Assessment Forecasting PharmDelve Competitive Analysis Pipeline Consulting Report Store • DelveInsight © 2019 | All rights reserved

  9. Contact Us info@delveinsight.com +91-11-4568 9769 www.delveinsight.com blog/delveInsight/ twitter/delveInsight LinkedIn/delveInsight • DelveInsight © 2019 | All rights reserved

  10. DelveInsight © 2019 | All rights reserved

More Related